Polycystin-1 dysfunction impairs electrolyte and water handling in a renal precystic mouse model for ADPKD by Verschuren, E.H.J. et al.
Submitted to Am J Physiol Renal Physiol #F-00622-2017R2 
 
 1 
POLYCYSTIN-1 DYSFUNCTION IMPAIRS ELECTROLYTE AND WATER HANDLING 2 
IN A RENAL PRE-CYSTIC MOUSE MODEL FOR ADPKD 3 
 4 
 5 
 6 
 7 
Eric H.J. Verschuren1, Sami G. Mohammed1, Wouter N. Leonhard2,  8 
Caro Overmars-Bos1, Kimberly Veraar2, Joost G.J. Hoenderop1,  9 
René J.M. Bindels§,1, Dorien J.M. Peters§,2, Francisco J. Arjona#,§,1 10 
 11 
 12 
 13 
 14 
 15 
1 Department of Physiology, Radboud Institute for Molecular Life Sciences,  16 
Radboud university medical center, Nijmegen, The Netherlands  17 
 18 
2 Department of Human Genetics, Leiden University Medical Centre,  19 
Leiden, The Netherlands  20 
 21 
 22 
 23 
 24 
 25 
Short Title: Renal electrolyte handling in a pre-cystic ADPKD model 26 
 27 
§ These authors have contributed equally to this work 28 
# Author for correspondence 29 
Name: Francisco J. Arjona 30 
Address: Department of Physiology, Radboud Institute for Molecular Life Sciences, Radboud 31 
university medical center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands 32 
Email: Francisco.ArjonaMadueno@radboudumc.nl 33 
 2 
ABSTRACT 34 
The PKD1 gene encodes polycystin-1 (PC1), a mechanosensor triggering intracellular responses 35 
upon urinary flow sensing in kidney tubular cells. Mutations in PKD1 lead to autosomal dominant 36 
polycystic kidney disease (ADPKD). The involvement of PC1 in renal electrolyte handling remains 37 
unknown since renal electrolyte physiology in ADPKD patients has only been characterized in 38 
cystic ADPKD. We thus studied the renal electrolyte handling in inducible kidney-specific Pkd1 39 
knockout (iKsp-Pkd1-/-) mice manifesting a pre-cystic phenotype. Serum and urinary electrolyte 40 
determinations indicated that iKsp-Pkd1-/- mice display reduced serum levels of magnesium 41 
(Mg2+), calcium (Ca2+), sodium (Na+) and phosphate (Pi) compared with control (Pkd1
+/+) mice; 42 
and renal Mg2+, Ca2+ and Pi wasting. In agreement with these electrolyte disturbances, 43 
downregulation of key genes for electrolyte reabsorption in the thick ascending limb of Henle's 44 
loop (TAL, Cldn16, Kcnj1 and Slc12a1), distal convoluted tubule (DCT, Trpm6 and Slc12a3) and 45 
connecting tubule (CNT, Calb1, Slc8a1, Atp2b4) was observed in kidneys of iKsp-Pkd1-/- mice 46 
compared with controls. Similarly, decreased renal gene expression of markers for TAL (Umod) 47 
and DCT (Pvalb) was observed in iKsp-Pkd1-/- mice. Conversely, mRNA expression levels in 48 
kidney of genes encoding solute and water transporters in the proximal tubule (Abcg2 and 49 
Slc34a1) and collecting duct (Aqp2, Scnn1a and Scnn1b) remained comparable between control 50 
and iKsp-Pkd1-/- mice, though a water reabsorption defect was observed in iKsp-Pkd1-/- mice. In 51 
conclusion, our data indicate that PC1 is involved in renal Mg2+, Ca2+ and water handling, and its 52 
dysfunction resulting in a systemic electrolyte imbalance characterized by low serum electrolyte 53 
concentrations.  54 
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INTRODUCTION 60 
The primary function of the kidneys is the removal of waste products from our metabolism. This 61 
process accounts for the challenge of filtering an average of 180 liters of blood daily. Upon 62 
filtration, the kidney reabsorbs 95% of the electrolytes contained in the filtrate. Consequently, a 63 
minor loss of kidney function yields disturbed plasma concentrations due to excessive urinary 64 
electrolyte excretion or absorption. This dysregulation of the electrolyte balance results in renal 65 
and extrarenal disorders including hypertension, renal stone formation and development of 66 
cardiovascular calcifications (8, 14, 21). 67 
 In the nephron, consecutive epithelial segments, i.e. the proximal tubule (PT), the thick 68 
ascending limb of Henle’s loop (TAL), the distal convoluted tubule (DCT), the connecting tubule 69 
(CNT) and the collecting duct (CD), maintain electrolyte balance through passive and/or active 70 
regulation of electrolyte reabsorption. Renal electrolyte handling is accomplished through the 71 
interplay of various tight junction proteins and ion channels and transporters expressed alongside 72 
the nephron (2, 19, 31, 41, 49). It is largely unknown how the activity of these channels and 73 
transporters is regulated. One of the factors that may comprise this regulation is the variable 74 
urinary flow in the nephron tubules. After all, renal electrolyte transport needs to be adjusted to 75 
the reabsorption demands that are dictated by the variable urinary flow in order to maintain 76 
electrolyte balance. In this context, it appears that tubular variable urinary flow is sensed by 77 
primary cilia, which are expressed in almost all epithelial cells within the kidney (9). The protein 78 
polycystin-1 (PC1), located at the cellular apical plasma membrane and in primary cilia (protruding 79 
from the apical surface of renal tubular cells), is suggested to act as a mechanosensory molecule 80 
for urinary flow (24, 33, 45, 56). 81 
The gene PKD1 encodes PC1 and is involved in the regulation of various signaling 82 
pathways important for the maintenance and differentiation of kidney tubular epithelial cells (5). 83 
Mutations in PKD1 lead to autosomal dominant polycystic kidney disease (ADPKD), which is one 84 
of the most common inherited renal diseases accounting for 7 to 10% of all patients on renal 85 
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replacement therapy (16, 38). ADPKD is characterized by increased cell proliferation, fluid 86 
accumulation and altered extracellular matrix synthesis, resulting in cyst formation and eventually 87 
in end-stage renal disease (ESRD). In advanced ADPKD, hypertension is common and 88 
glomerular filtration rate (GFR) is reduced (6, 48). Electrolyte disturbances in ADPKD are 89 
described in literature, but these reports are mostly restricted to cystic ADPKD (4, 11, 13, 34, 39, 90 
40, 43, 44, 47, 51, 55, 57, 58). When electrolyte imbalances are detected in cystic ADPKD, it is 91 
not possible to discern whether these disturbances are caused by dysfunctional PC1 or by cyst 92 
formation or defects in GFR, which dramatically impair renal fluid flow and blood filtration, 93 
respectively. In Pkd1+/- mice, urinary wasting of Na+, and reduced urinary Ca2+ excretion and 94 
serum Na+ levels have been reported (1). However, Pkd1+/- mice are not adequate to disclose 95 
PC1 function since one Pkd1 allele still translates into a functional PC1 protein, while Pkd1-/- mice 96 
die prematurely. Therefore, use of kidney-specific Pkd1-/- mice, which are viable (27) and in a 97 
stage preceding cyst formation (pre-cystic), is key to elucidate the involvement of PC1 in renal 98 
electrolyte handling. Identification of putative electrolyte disturbances in kidney-specific Pkd1-/- 99 
mice can be of paramount relevance to fully characterize the function of PC1 and thus delineate 100 
the physiological consequences of sensing urinary flow along the nephron. 101 
The aim of this study was, therefore, to study the function of PC1 in renal electrolyte 102 
handling in relation to pre-cystic ADPKD by using an inducible kidney-specific Pkd1-/- mouse 103 
model. 104 
 105 
 106 
METHODS 107 
 108 
Animal Procedures 109 
Inducible kidney-specific Pkd1 knockout mice (iKsp-Pkd1lox/lox) were used during experimentation. 110 
In this mouse model, the Pkd1lox/lox allele has Lox-P sites flanking exons 2-11. Tamoxifen was 111 
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orally administered to iKsp-Pkd1lox/lox mice on postnatal days 18, 19 and 20 (PN18) to induce a 112 
kidney specific knockout of Pkd1 (iKsp-Pkd1-/-) and thus model ADPKD (27, 28). For 113 
experimentation, 8 male mice (obtained from 3 litters) received tamoxifen (iKsp-Pkd1-/-) and 7 114 
male mice (obtained from 3 litters) received no treatment (control). Only male mice were used in 115 
order to exclude sex as a factor influencing electrolyte handling since estrogen can influence Mg2+ 116 
absorption rates (8). At PN18 + 22 days and at PN18 + 29 days, mice were placed in metabolic 117 
cages for 24hrs to collect urine and faeces. Subsequently, body weight, faeces weight, urinary 118 
volume, food and water intake were assessed. Next, mice were anesthetized using isoflurane, 119 
and blood was collected via eye extraction. Finally, mice were sacrificed by cervical dislocation. 120 
Serum was obtained from the blood by centrifugation. Kidneys were extracted and weighed, and 121 
different segments of the intestine were collected in liquid nitrogen and stored at -80°C for mRNA 122 
and protein isolation. Part of the kidney was fixed in 4% (v/v) formalin before imbedding in paraffin 123 
for immunohistochemistry. Urine and faeces were stored at -20°C for assessment of the 124 
electrolyte content. The local animal experimental committee of the Leiden University Medical 125 
Center and the Commission Biotechnology in Animals of the Dutch Ministry of Agriculture 126 
approved the animal procedures performed.  127 
 128 
Analytical Procedures 129 
Serum, urinary and faecal electrolyte content was measured using inductively coupled plasma 130 
mass spectrometry (ICP-MS, ppb, for Mg2+, Ca2+, Na+ and K+), a chloride autoanalyzer (ppb, for 131 
Cl-), and inductively coupled plasma optic emission spectrometry (ICP-OES, ppm, for total 132 
phosphorus (as a measurement of inorganic phosphate, Pi)). Samples were prepared by 133 
dissolving 20μl of serum or urine in 50μl nitric acid (HNO3) and further diluted in 5ml MQ water. 134 
Faeces were incubated in 10ml HNO3 at 50°C for 1hr. Next, total faeces samples were diluted 135 
with 10ml MQ water, homogenized by shaking, and 100μl of sample was further diluted with 5ml 136 
MQ. Diluted samples were then analyzed for electrolyte content. In addition, blood urea nitrogen 137 
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(BUN, mg/dl) was analyzed in the serum. Serum glucose (mmol/L) was analyzed using a glucose 138 
liquicolor kit (HUMAN GmbH, Germany). Osmolality (mOsm/kg) was assessed in the urine and 139 
serum using an osmometer (Osmometer Model 3320, Advanced Instruments Inc, MA, USA). 140 
Furthermore, the calculated serum osmolarity was determined using the following formula: 2 x 141 
serum[Na+] + serum[glucose] + [BUN] (52). Non-acetylated cAMP (nmol/24-hrs) was analyzed in 142 
the urine using a nonradioactive enzyme immunoassay kit (Cayman Chemical, MI, USA). The 143 
weight of both kidneys (2KW) was compared to the total body weight (BW) in order to determine 144 
the 2KW/BW ratios (%) for each mouse.  145 
 146 
Histology & Cystic Index 147 
Formalin fixed kidneys were embedded in paraffin and sections (4μm) were prepared. Sections 148 
were stained with periodic-acid Schiff (PAS) and hematoxylin and eosin (HE) using standard 149 
procedures. PAS and HE stainings were analyzed in order to examine features such as tubular 150 
dilation and/or cyst formation. The cystic index of kidneys from control and iKsp-Pkd1-/- mice was 151 
defined as the percent of lumen area over the total image area and assessed from total scans of 152 
hematoxylin and eosin-stained kidney sections (Figure 1). The stained lumen content of larger 153 
dilations and/or potential small cysts was removed from the images using Photoshop CC 2017 154 
(Adobe Systems, CA, USA). Cystic index, using the ratio of total renal area plus lumen and total 155 
renal area minus lumen was determined by ImageJ software (National Institute of Health, MA, 156 
USA). 157 
 158 
Immunohistochemistry 159 
Specific nephron segments were distinguished by immunofluorescence using segment specific 160 
primary antibodies, namely rat anti-breast cancer resistance protein (BCRP) for the PT (1:250 in 161 
Tris-NaCl-blocking buffer (TNB), Kamiya Biomedical Company, WA, USA), sheep anti-Tamm-162 
Horsfall protein (THF) for the TAL (1:200 in TNB, Biotrend, Germany), rabbit anti-NCC for the 163 
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DCT (1:200 in TNB, Millipore, MA, USA), guinea pig anti-TRPV5 for the CNT (1:2000 in TNB) (20) 164 
and rabbit anti-Aquaporin-2 (AQP2) for the CD (1:100 in TNB, Millipore, MA, USA). Sections were 165 
deparaffinized in xylene and subjected to heat-mediated antigen retrieval in citrate buffer (pH 6.0, 166 
Sigma-Aldrich, MI, USA) for 15min. Sections were incubated in 0.1% (v/v) PBS-Triton for 15min 167 
for permeabilization. Sections with staining for BCRP, THF, NCC and AQP2 were blocked for 168 
30min in TNB and incubated with primary antibodies overnight. Next, sections were washed with 169 
Tris-NaCl (TN-Tween) buffer and incubated with secondary antibodies for 1hr in dark at room 170 
temperature: goat anti-rat Cy5 (1:100 in TNB, for BCRP, Jackson ImmunoResearch, PA, USA), 171 
goat anti-sheep Alexa594 (1:300 in TNB, for THF, Molecular Probes, OR, USA) and goat anti-172 
rabbit Alexa594 (1:300 in TNB, for NCC and AQP2, Molecular Probes, OR, USA). Finally, sections 173 
were washed with TN buffer and mounted (DAPI Fluoromount-G, SouthernBiotech, AL, USA). 174 
For anti-TRPV5, after permeabilization, sections were blocked with 0.3% (v/v) H2O2 for 30min for 175 
endogenous peroxidase activity. Next, sections were blocked with a few droplets of endogenous 176 
Avidin and Biotin (Vector Laboratories, CA, USA) for 15min each. Subsequently, sections were 177 
blocked using TNB for 30min and incubated with primary antibody overnight. Next, sections were 178 
washed with TN-Tween buffer and incubated with secondary antibody for 1hr in dark at room 179 
temperature: goat anti-guinea pig Biotin SP (1:2000 in TNB, Jackson ImmunoResearch, PA, USA). 180 
Subsequently, sections were incubated in strep-HRP (1:100 in TNB, PerkinElmer, MA, USA) for 181 
30min followed by fluorescein tyramide (1:50 in amplification diluent, PerkinElmer, MA, USA) for 182 
7min. Finally, sections were mounted (DAPI Fluoromount-G, SouthernBiotech, AL, USA) and 183 
analyzed with a fluorescence microscope (Axio Imager 2, Zeiss, Germany). 184 
 185 
Quantitative Real-Time PCR 186 
Tissue RNA was extracted using TriZol/chloroform extraction (Invitrogen, CA, USA). After DNase 187 
treatment (Promega, WI, USA), cDNA was synthesized using Molony-Murine Leukemia Virus-188 
Reverse Transcriptase (Invitrogen, CA, USA) as previously described (18). The cDNA was mixed 189 
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with Power SYBR green PCR master mix (Applied Biosystems, CA, USA) and with primers 190 
(400nM) for the gene of interest as previously described (3). The expression of the following genes 191 
was assessed via RTqPCR (7min at 95°C, 40 cycles of 15 sec at 95°C and 1 min at 60°C) in the 192 
kidney; Abcg2, Atp2b4, Aqp2, Calb1, Cldn16, Cldn19, Cnnm2, Kcnj1, Kim-1, Prom1, Prom2, 193 
Pvalb, Scnn1a, Scnn1b, Slc8a1, Slc12a1, Slc12a3, Slc34a1, Slc41a3, Trpm6, Trpm7, Trpv5 and 194 
Umod (Table 1). In the intestine, the expression of the following genes was assessed: Atp2b4, 195 
Cnnm4, Trpm6 and Trpv6. As a reference gene, Gapdh was used, and negative controls (samples 196 
where the reverse transcriptase was omitted during cDNA synthesis, and non-template samples) 197 
were taken along with each gene. The relative gene expression was analyzed using the Livak 198 
method (2-ΔΔCt).  199 
 200 
Statistical Analyses 201 
Differences between groups were assessed using an unpaired Student's t-test. All data were 202 
expressed as mean ± SEM. Statistical significance was accepted at P < 0.05. Statistical analyses 203 
were performed using GraphPad Prism 6 (GraphPad, San Diego, CA, USA).  204 
 205 
 206 
RESULTS 207 
 208 
Pre-cystic kidneys of iKsp-Pkd1-/- mice do not manifest tubular dilation in TAL, DCT and 209 
CNT 210 
Normal renal histology was observed in the kidneys of mice treated without tamoxifen (controls) 211 
by Periodic acid-Schiff (PAS) staining, whereas tamoxifen-treated mice (kidney specific Pkd1-/- 212 
(iKsp-Pkd1-/-) mice) displayed mild dilated tubules in the cortex, outer and inner medulla at PN18 213 
+ 29 days (Figure 1, 2A). In detail, after immunofluorescent staining for specific nephron segments, 214 
only mild tubular dilation, restricted to the PT and CD, was observed. Importantly, no tubular 215 
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dilation was observed in TAL, DCT and CNT (Figure 2B). Remarkably, at this pre-cystic stage, 216 
Kim-1 (Kidney injury molecule-1) mRNA expression was significantly increased (P < 0.05), 217 
whereas the Blood Urea Nitrogen (BUN) levels were not altered between control and iKsp-Pkd1-218 
/- mice (Figure 2C-D). Furthermore, a significantly increased 2KW/BW ratio (1.3 ± 0.1% and 1.6 ± 219 
0.1% for control versus iKsp-Pkd1-/- mice, respectively, P < 0.05) and cystic index (1.8 ± 0.2% 220 
and 3.6 ± 0.4% for control versus iKsp-Pkd1-/- mice, respectively, P < 0.05) was observed (Figure 221 
2E-F), indicative of enlargement of the kidneys due to the mild tubular dilations seen in the PT 222 
and CD. 223 
 224 
Pre-cystic iKsp-Pkd1-/- mice display disturbances in renal electrolyte and water handling 225 
Serum and 24-hrs urine were collected to characterize the renal electrolyte and water handling in 226 
iKsp-Pkd1-/- mice with pre-cystic kidneys, and in control mice. In detail, at PN18 + 22 days, urinary 227 
wasting of Ca2+ and Mg2+ was observed (P < 0.05) (Table 2); however, this effect was not 228 
observed at PN18 + 29 days (Table 2). Conversely, analysis at PN18 + 29 days showed that iKsp-229 
Pkd1-/- mice exhibited lower serum Ca2+, Mg2+, Na+ and Pi levels (P < 0.05) and a renal Pi leakage 230 
(P < 0.05) (Table 2). A non-statistically significant increase in urinary volume was observed in 231 
iKsp-Pkd1-/- mice as compared to controls (P = 0.23 and P = 0.08 for PN18 + 22 days and PN18 232 
+ 29 days, respectively). No changes in urine osmolality and cAMP levels at PN18 + 22 days 233 
were observed. However, at PN18 + 29 days, urine osmolality was significantly lower (P < 0.05) 234 
in iKsp-Pkd1-/- versus control mice. At this time point, urinary cAMP was significantly higher (P < 235 
0.05) in iKsp-Pkd1-/- mice as compared to controls (Table 2), indicating an activation of the 236 
arginine vasopressin (AVP)-cAMP-AQP2 axis. Significant changes in serum glucose were not 237 
observed between iKsp-Pkd1-/- and control mice at PN18 + 29 days. Serum osmolality was similar 238 
between iKsp-Pkd1-/- and control mice at PN18 + 29 days. The calculated serum osmolarity was 239 
significantly lower in iKsp-Pkd1-/- mice as compared to controls. Furthermore, control and iKsp-240 
Pkd1-/- mice had a comparable food and water intake (Table 2). 241 
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 242 
Decreased expression of key genes for electrolyte reabsorption in TAL, DCT and CNT  243 
To assess whether the electrolyte imbalances in iKsp-Pkd1-/- mice resulted from aberrant gene 244 
expression, the mRNA expression of key genes relevant for electrolyte handling in the kidney 245 
were examined. At PN18 + 29 days, downregulation of the mRNA levels in whole kidney of several 246 
key genes for electrolyte reabsorption in TAL, DCT and CNT was observed in iKsp-Pkd1-/- mice 247 
compared to control mice. In TAL, the expression of Cldn16 (Claudin16), Kcnj1 (ROMK) and 248 
Slc12a1 (NKCC2) was decreased (P < 0.05) (Figure 3B). In DCT, reduced expression of Trpm6 249 
(TRPM6) and Slc12a3 (NCC) was observed (P < 0.05) (Figure 3C). The expression of Calb1 250 
(Calbindin1), Slc8a1 (NCX1) and Atp2b4 (PMCA4) was downregulated in the CNT (P < 0.05) 251 
(Figure 3D). Genes encoding channels and transporters in the PT (Abcg2 and Slc34a1) and CD 252 
(Aqp2, Scnn1a and Scnn1b) were not affected (Figure 3A, 3E). Gene expression of Trpm7 253 
(TRPM7), a gene ubiquitously expressed along the nephron, was similar in iKsp-Pkd1-/- and 254 
control mice (Figure 3F).  255 
 256 
Decreased gene expression of renal segment markers in pre-cystic iKsp-Pkd1-/- mice 257 
The expression of Umod (Uromodulin), a marker of the TAL (46), and Pvalb (Parvalbumin), a 258 
marker of the DCT (36), was downregulated in iKsp-Pkd1-/- mice compared to control mice (P < 259 
0.05) (Figure 4A). Furthermore, decreased expression of Prom2 (Prominin-2), a marker of TAL, 260 
DCT, CNT and CD was also observed iKsp-Pkd1-/- mice compared to control mice (P < 0.05), 261 
whereas Prom1 (Prominin-1) expression, a marker of the PT (23), was similarly expressed in the 262 
kidneys of control and iKsp-Pkd1-/- mice (Figure 4B). 263 
 264 
 265 
Compensation of the renal electrolyte disturbances in the intestine 266 
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In order to disclose extra-renal mechanisms compensating for the electrolyte imbalances elicited 267 
by knocking out Pkd1 in the mouse kidney, we assessed the mRNA expression of genes relevant 268 
for electrolyte handling in the intestine. Interestingly, Trpv6 (TRPV6) expression was increased in 269 
the duodenum (P < 0.05) of iKsp-Pkd1-/- mice as compared to controls (Figure 5A), whereas in 270 
colon, Trpm6 expression was decreased (P < 0.05). In duodenum and caecum, no changes in 271 
Trpm6 expression were observed. Furthermore, in colon and caecum, no changes in gene 272 
expression were observed between iKsp-Pkd1-/- and control mice for Cnnm4, Trpv6 and Atp2b4 273 
(Figure 5B, 5C). 274 
 275 
 276 
DISCUSSION 277 
This study is the first characterization of the renal electrolyte and water handling in a model of 278 
ADPKD during the renal pre-cystic phase. We show that the knockout of PC1 in the mouse kidney 279 
leads to decreased serum Mg2+, Ca2+, Na+ and Pi levels; and urinary wasting of Mg2+ and Ca2+ 280 
during the pre-cystic stage, illustrating the role of PC1 in renal Mg2+ and Ca2+ handling. In addition, 281 
our data support the involvement of PC1 in the regulation of water reabsorption in the kidney. The 282 
Mg2+ and Ca2+ imbalances elicited by dysfunctional PC1 were likely caused by a decrease in the 283 
expression of key genes for the reabsorption of Mg2+and Ca2+ in TAL, DCT and CNT of the 284 
nephron.  285 
By characterizing the renal electrolyte and water handling, and its influence on serum 286 
electrolyte levels, in the renal pre-cystic stage of iKsp-Pkd1-/- mice, information about the early 287 
stages of development of ADPKD is provided. Most studies using models for ADPKD have only 288 
investigated renal cystic stages, and thus, later stages to the pre-cystic phase. The mice used in 289 
our study clearly show a renal pre-cystic phenotype. This is supported by the low 2KW/BW ratios, 290 
the low cystic index, and the absence of cysts in the PAS-stained kidney sections of Pkd1-/- mice. 291 
We only observed a mild tubular dilation restricted to the PT and CD (cystic index: 3.6 ± 0.4%). 292 
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Models with a cystic phenotype generally display a cystic index of 20 to 60%, depending on the 293 
model (10, 17, 28, 35).  294 
iKsp-Pkd1-/- mice showed renal Mg2+ and Ca2+ wasting at PN18 + 22 days, pointing to a 295 
role of PC1 in the reabsorption of Mg2+ and Ca2+ in the kidney. This Mg2+ and Ca2+ leak in the 296 
kidney of iKsp-Pkd1-/- mice was manifested as reduced serum Mg2+ and Ca2+ levels as compared 297 
with control mice at a later time point of PN18 + 29 days. Changes in urinary electrolyte excretion 298 
precede changes in serum electrolyte concentrations (12). Thus, the renal Mg2+ and Ca2+ leak 299 
detected in iKsp-Pkd1-/- mice compared to control mice at PN18 + 22 days illustrates evolving 300 
systemic (serum) Mg2+ and Ca2+ disturbances, which become apparent at PN18 + 29 days. The 301 
comparable Mg2+ and Ca2+ excretion between control and iKsp-Pkd1-/- mice at PN18 + 29 days 302 
illustrate further the inability of the kidneys at this time point to restore the serum electrolyte 303 
balance by increasing Mg2+ and Ca2+ reabsorption. These data are consistent with adult Slc41a3-304 
/- and Trpm6+/- mice of 8-12 weeks, that display lower serum Mg2+ concentrations and a 305 
comparable urinary Mg2+ excretion compared with control (Slc41a3+/+ and Trpm6+/+, respectively) 306 
mice (7, 54).  307 
In addition to renal Mg2+ and, Ca2+ wasting, urinary Pi excretion was increased in iKsp-308 
Pkd1-/- mice compared to control mice at PN18 + 29 days. This finding relates PC1 function to the 309 
control of renal Pi excretion in addition to regulating renal Mg2+ and Ca2+ handling. 310 
In agreement with the decreased Na+ levels in serum found in our iKsp-Pkd1-/- mice 311 
compared with control mice, haploinsufficient Pkd1 mice that do not develop cysts, had lower 312 
serum Na+ levels than Pkd1+/+ mice (1). A decreased serum Na+ concentration relates to an 313 
excess of water in the blood (32) or a renal salt wasting resulting in hypovolaemia (30). However, 314 
control and iKsp-Pkd1-/- mice had a similar serum osmolality (PN18 + 29 days), though the 315 
calculated serum osmolarity was lower in iKsp-Pkd1-/- mice. Control and iKsp-Pkd1-/- mice 316 
displayed a comparable water intake and urine output, not indicating water overload or 317 
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hypovolaemia, respectively. Thus, the origin of the lower levels of Na+ in the serum of iKsp-Pkd1-318 
/- mice compared with controls remains elusive.      319 
In contrast with serum osmolality, urine osmolality was significantly decreased at PN18 + 320 
29 days in iKsp-Pkd1-/- mice as compared to controls. Taking into account the increase in urine 321 
production between iKsp-Pkd1-/- versus control mice (though not statistically significant) (Table 2), 322 
these data clearly indicate an inability of the kidneys of iKsp-Pkd1-/- mice to concentrate ions in 323 
urine. This is supported by increased urinary cAMP levels in iKsp-Pkd1-/- mice, which indicates a 324 
compensatory response to the decreased water reabsorption by activation of the AVP-cAMP-325 
AQP2 axis (42).  326 
Importantly, BUN, a common marker for kidney function, remained unchanged in Pkd1-/- 327 
mice, indicating that the disturbances in Mg2+, Ca2+ and Na+ balance observed are not caused by 328 
defects in glomerular filtration. However, an increase in the expression of Kim-1 in the pre-cystic 329 
kidneys of iKsp-Pkd1-/- mice was observed as compared with control mice. These findings point 330 
to mild tubular injury as a result of Pkd1 gene disruption. Kim-1 encodes a membrane protein, 331 
which is up-regulated in proliferating and dedifferentiated tubular cells after renal ischemia (25). 332 
Kim-1 is postulated to be a potential biomarker for ADPKD progression (15, 39). Our data further 333 
support this notion, especially when considering ADPKD in a pre-cystic stage.  334 
The underlying cause of the impaired renal Mg2+ and Ca2+ handling observed in iKsp-335 
Pkd1-/- mice is likely the decreased renal gene expression of Cldn16, Kcnj1 and Slc12a1, key 336 
genes for paracellular Mg2+ and Ca2+ transport in the TAL; of Trpm6, Slc12a3 and Cnnm2, relevant 337 
genes for transcellular Mg2+ reabsorption in the DCT; and Calb1, Slc8a1 and Atp2b4, genes 338 
coding the players that facilitate transcellular Ca2+ reabsorption in the CNT. Some of these genes, 339 
i.e. Cldn16, Slc12a1 and Slc12a3, encode proteins that are also involved in Na+ reabsorption and 340 
thus might evoke aberrant renal Na+ transport in iKsp-Pkd1-/- mice. Therefore, renal PC1 341 
dysfunction seems to predominantly affect the TAL, DCT and CNT of the nephron, eliciting 342 
aberrant gene expression of regulators of Mg2+, Ca2+ and Na+ transport in these segments. In 343 
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contrast with serum Na+ levels, the concentration of Ca2+ and Mg2+ in serum is influenced by renal 344 
Mg2+ and Ca2+ transport (8). Thus, the decreased expression of genes relevant for Mg2+ and Ca2+ 345 
in the TAL, DCT and CNT, can explain the lower serum Mg2+ and Ca2+ concentrations observed 346 
in iKsp-Pkd1-/- mice compared to controls. In addition, a compensatory mechanism for the renal 347 
Ca2+ leak was detected in the duodenum of iKsp-Pkd1-/- mice as an increased mRNA expression 348 
of Trpv6 was observed in this segment of the intestine in comparison with control mice. The same 349 
phenomenon was observed in wild-type mice on a low Ca2+ diet in a previous study (53). 350 
Conspicuously, in correlation with the decreased expression of key genes for electrolyte 351 
reabsorption in the kidney, a lower gene expression of TAL (Umod) and DCT (Pvalb) segment 352 
markers was observed in iKsp-Pkd1-/- compared to control mice, pointing to a potential remodeling 353 
of TAL and DCT segments evoked by renal PC1 dysfunction. This finding is supported by the 354 
decreased expression of Prom2, a marker for TAL, DCT, CNT and CD, whereas the expression 355 
of Prom1, a marker for PT, was not decreased in iKsp-Pkd1-/- mice when compared to control 356 
mice. While remodeling events, eventually leading to cyst formation, are clearly intertwined with 357 
ADPKD (5, 38), this study is the first to show that remodeling due to PC1 dysfunction in a pre-358 
cystic context results in broad electrolyte imbalances. The association of the electrolyte 359 
imbalances in iKsp-Pkd1-/- mice with remodeling events in the kidney is congruent with the de-360 
differentiation and persistent cell proliferation already reported for altered PC1 expression in 361 
kidneys (22, 29). 362 
In conclusion, we have demonstrated that dysfunction of PC1 impairs renal Mg2+, Ca2+ 363 
and water reabsorption in pre-cystic kidneys leading to serum Mg2+ and Ca2+ levels. These 364 
electrolyte disturbances preceding cyst formation observed in our model provide novel insights 365 
into PC1 function (Table 3). More research is required to disclose whether the electrolyte 366 
disturbances shown in this study might serve as early biomarkers of disease progression in 367 
ADPKD and/or might aid the development of treatment options in this early stage of the disease.  368 
 369 
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FIGURE LEGENDS  558 
 559 
Figure 1. Illustrative examples of the images used for the calculation of the cystic index in 560 
iKsp-Pkd1-/- and control kidneys. The cystic index of kidneys from control and iKsp-Pkd1-/- mice 561 
were assessed from total scans of hematoxylin and eosin-stained kidneys sections (A, D). The 562 
area of the total kidney minus the stained lumen area was calculated (C, F) and subtracted from 563 
the total renal plus lumen area (B, E). 564 
 565 
Figure 2. Kidneys of iKsp-Pkd1-/- mice display a pre-cystic phenotype at PN18 + 29 days. 566 
(A, B and C) iKsp-Pkd1lox/lox mice untreated (control) or treated (kidney specific Pkd1-/-) with 567 
tamoxifen on post natal days 18, 19 and 20 (PN18) and sacrificed 29 days later (PN18 + 29 days). 568 
(A) Periodic acid-Schiff (PAS) staining indicating normal renal histology in mice without tamoxifen 569 
treatment (control) and mild tubular dilation 29 days after tamoxifen treatment (Pkd1-/-). Mild 570 
tubular dilation is observed in the cortex, outer and inner medulla. (B) Mild tubular dilation was 571 
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observed predominantly in the PT (anti-BCRP, green) and CD (anti-AQP2, red). No significant 572 
tubular dilation was observed in the TAL (anti-THF, red), DCT (anti-NCC, red) and CNT (anti-573 
TRPV5, green). (C) Increased Kim-1 mRNA expression observed in pre-cystic kidneys of Pkd1-/- 574 
mice. (D) Blood Urea Nitrogen (BUN) levels displayed as mg/dL, no significant differences were 575 
observed. (E) Ratio of the kidney weight to body weight expressed as a percentage (2KW/BW %) 576 
and (F) the calculated cystic index showing the percentage of dilated/cystic area, values are 577 
presented as means ± SEM (n = 7-8), *P < 0.05 is considered statistically significant. 578 
 579 
Figure 3.  Renal expression of transporters relevant for electrolyte reabsorption. (A-F) iKsp-580 
Pkd1lox/lox mice were either untreated (control, white bars) or treated (kidney specific Pkd1-/-, black 581 
bars) with tamoxifen on post natal days 18, 19 and 20 (PN18) and sacrificed 29 days later (PN18 582 
+ 29 days). (A) Relative mRNA expression of genes enriched in the PT. The genes assessed 583 
were Abcg2 (encoding BCRP) and Slc34a1 (encoding NaPi-2a). (B) Relative mRNA expression 584 
of genes enriched in the TAL. Genes measured were Cldn19, Cldn16, Kcnj1 (encoding ROMK) 585 
and Slc12a1 (encoding NKCC2). (C) Relative mRNA expression of genes enriched in the DCT. 586 
Genes measured were Trpm6, Slc12a3 (encoding NCC), Cnnm2 and Slc41a3. (D) Relative 587 
mRNA expression of genes enriched in the CNT. Genes measured were Trpv5, Calb1 (encoding 588 
calbinin-D28K), Slc8a1 (encoding NCX1) and Atp2b4 (encoding PMCA4A). (E) Relative expression 589 
to controls of genes enriched in the CD. Genes measured were Aqp2, Scnn1a (encoding ENaCα) 590 
and Scnn1b (encoding ENaCβ). (F) Relative mRNA expression of Trpm7 (ubiquitous expressed 591 
along the nephron). (A-F) mRNA levels were assessed by RTqPCR and normalized against the 592 
reference gene Gapdh. Gene expression data were calculated using the Livak method (2−ΔΔCt), 593 
and they represent the mean fold difference (mean ± SEM, n = 7-8) from the calibrator group 594 
(control mice). *P < 0.05 is considered statistically significant. 595 
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 596 
Figure 4. Decreased gene expression of markers for TAL and DCT. (A-B) iKsp-Pkd1lox/lox mice 597 
were either untreated (control, white bars) or treated (kidney specific Pkd1-/-, black bars) with 598 
tamoxifen on post natal day 18, 19 and 20 (PN18) and sacrificed 29 days later (PN18 + 29 days). 599 
(A) Relative mRNA expression of genes encoding specific renal segment markers, namely Umod 600 
(encoding Uromodulin) for the TAL and Pvalb (encoding Parvalbumin) for the DCT. (B) Relative 601 
mRNA expression of genes encoding for a specific marker of the PT, namely Prom1 (encoding 602 
Prominin-1) and Prom2 (encoding Prominin-2), a marker for distal tubules. mRNA expression 603 
levels were assessed by RTqPCR and normalized against the reference gene Gapdh. Gene 604 
expression data were calculated using the Livak method (2−ΔΔCt), and they represent the mean 605 
fold difference (mean ± SEM, n = 7-8) from the calibrator group (control mice). *P < 0.05 is 606 
considered statistically significant. 607 
 608 
Figure 5. Intestinal expression of transporters relevant for electrolyte reabsorption. (A-C) 609 
iKsp-Pkd1lox/lox mice were either untreated (control, white bars) or treated (kidney specific Pkd1-/-, 610 
black bars) with tamoxifen on post natal day 18, 19 and 20 (PN18) and sacrificed 29 days later 611 
(PN18 + 29 days). Relative mRNA expression of key genes for Ca2+ and Mg2+ absorption in the 612 
duodenum (A), caecum (B) and colon (C). Genes assessed were Trpm6, Cnnm4, Trpv6 and 613 
Atp2b4 (encoding PMCA4A). mRNA levels were assessed by RTqPCR and normalized against 614 
the reference gene Gapdh. Gene expression data were calculated using the Livak method (2−ΔΔCt), 615 
and they represent the mean fold difference (mean ± SEM, n = 7-8) from the calibrator group 616 
(control mice). *P < 0.05 is considered statistically significant. 617 
